The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man.
作者信息
GOLDBERG L I, BLOODWELL R D, BRAUNWALD E, MORROW A G
出版信息
Circulation. 1960 Dec;22:1125-32. doi: 10.1161/01.cir.22.6.1125.
PMID:13706460
Abstract
摘要
相似文献
1
The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man.
Circulation. 1960 Dec;22:1125-32. doi: 10.1161/01.cir.22.6.1125.
2
Effect of heart rate and intracoronary isoproterenol, levarterenol, and epinephrine on coronary flow and resistance.
Circ Res. 1961 Jan;9:89-95. doi: 10.1161/01.res.9.1.89.
3
4
[On the different way of modification of resistance and capacitance vessels by various sympathomimetics].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 18;252(2):103-21.
5
Prostaglandin-mediated inhibition of noradrenaline release: IV. Prostaglandin synthesis is stimulated by myocardial adrenoceptors differing from the alpha- and beta-type.
Acta Physiol Scand. 1978 Mar;102(3):374-81.
6
Cardiostimulatory effects of oxyfedrine, DMPP and sympathomimetics in relation to their 3H-noradrenaline-releasing properties.
Naunyn Schmiedebergs Arch Pharmakol. 1971;268(1):59-70. doi: 10.1007/BF00997173.
7
Comparative study of effects of levarterenol and methoxamine in shock associated with acute myocardial ischemia in dogs.
Circ Res. 1962 May;10:712-21. doi: 10.1161/01.res.10.5.712.
8
Adrenergic actions on heart rate, atrio-ventricular refractory period and intraventricular conduction in dogs.
Arch Int Physiol Biochim. 1964 Jan;72(1):44-65. doi: 10.3109/13813456409105251.
9
Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
J Pharmacol Exp Ther. 1972 Apr;181(1):116-25.
10
Cardiac actions of methoxamine with special reference to its antagonistic action to epinephrine.
Circ Res. 1961 May;9:552-60. doi: 10.1161/01.res.9.3.552.
引用本文的文献
1
Comparison of TWA and PEP as indices of α2- and ß-adrenergic activation.
Psychopharmacology (Berl). 2022 Jul;239(7):2277-2288. doi: 10.1007/s00213-022-06114-8. Epub 2022 Apr 8.
2
Norepinephrine, more than a vasopressor.
Ann Transl Med. 2019 Mar;7(Suppl 1):S25. doi: 10.21037/atm.2019.01.76.
3
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.
Elife. 2018 Oct 3;7:e40907. doi: 10.7554/eLife.40907.
4
Combining remote ischemic preconditioning and aerobic exercise: a novel adaptation of blood flow restriction exercise.
Am J Physiol Regul Integr Comp Physiol. 2017 Nov 1;313(5):R497-R506. doi: 10.1152/ajpregu.00111.2017. Epub 2017 Aug 23.
5
Hypertension-induced remodelling: on the interactions of cardiac risk factors.
J Physiol. 2017 Jun 15;595(12):4027-4036. doi: 10.1113/JP273043. Epub 2017 Mar 30.
6
A phenotypic in vitro model for the main determinants of human whole heart function.
Biomaterials. 2015 Aug;60:20-30. doi: 10.1016/j.biomaterials.2015.04.035. Epub 2015 May 14.
7
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.
Heart Fail Rev. 2010 Sep;15(5):495-512. doi: 10.1007/s10741-010-9183-5.
8
The effect of steady-state increases in systemic arterial pressure on the duration of left ventricular ejection time.
J Clin Invest. 1968 Jan;47(1):217-30. doi: 10.1172/JCI105711.
9
The effects of acute hypoxia on the systemic venous and arterial systems and on myocardial contractile force.
J Clin Invest. 1962 Jul;41(7):1553-63. doi: 10.1172/JCI104612.
10
STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN.
J Clin Invest. 1965 Sep;44(9):1494-504. doi: 10.1172/JCI105256.
Zotero 插件